• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

IAG-Supported Studies

Description: Conduct IAG-supported studies to enhance FDA science for hazard identification and risk assessment through toxicology studies (1).

Public Health Outcome: This IAG and supported studies will help in generating toxicology data for substances or agents of potential public health concern and will help in developing and evaluating and/or validating new toxicological methods.

Accomplishment: TBD

Briefing Status: COMPLETED

Prior Briefing Status: DELAYED

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Provide NTP with semi-annual report on IAG-support studies


Completed 5/1/2010

2. Produce biannual brochure on IAG-support studies






Completed 3/1/2012

3. Conduct spring semi-annual review of IAG-supported studies for the TSSRC


Completed 5/17/2010

4. Provide NTP with annual report on IAG-supported studies


Completed 10/1/2010

5. Submit FDA/NCTR Research Study Summaries for NTP Annual Plan


Completed 11/30/2010

6. Conduct fall semi-annual review of IAG-supported studies for TSSRC


Completed 11/17/2010


  • (1) NTP is an intra-Agency program between the National Institutes of Health (NIH) and NCTR whereby NIH directs the toxicological research and NCTR performs the research.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.



Interagency Agreement


National Toxicology Program


Toxicology Study Selection and Review Committee

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.